BDX: After 53 Years of Dividend Growth – Is This Stock Finally Worth Buying?

53 Years of Dividend Growth

In this video, Chuck Carnevale, co-founder of FAST Graphs, aka Mr. Valuation, discusses Becton Dickinson (BDX), 53 years of dividend growth, a medical diagnostics company that has increased its dividend for 53 consecutive years. Despite being a high-quality company with low debt and strong growth potential, the stock has recently taken a hit, making it an attractive value investment.

(Click on image to enlarge)

dividend growth

Chuck highlights that Becton Dickinson’s stock is currently priced at a low PE ratio of 12.6, below its typical valuation range, providing an opportunity for long-term investors. He emphasizes the company’s strong operating cash flow, consistent dividend growth, and the upcoming separation of its business units, which could unlock additional value. Chuck suggests that if the stock reverts to a higher valuation, it could provide significant returns. He concludes by recommending Becton Dickinson as a solid dividend play for value investors, noting that the company’s fundamentals remain strong despite current market challenges. Use your FAST Graphs to further your due diligence.

Video Length: 00:14:24